Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT06856850
What this trial is testing

Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)FTDNeuropathic+3 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 230
Not applicableActive Not RecruitingNCT06209515
What this trial is testing

Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study

Who this might be right for
Neurodegenerative DiseasesAlzheimer DiseaseFrontotemporal Dementia+8 more
Kuopio University Hospital 61,292
Very early researchStudy completedNCT02851914
What this trial is testing

SSRIs vs. TCAs for Depression in ALS Patients

Who this might be right for
DepressionAmyotrophic Lateral Sclerosis
St. Louis University 2
Not applicableActive Not RecruitingNCT06551649
What this trial is testing

Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation

Who this might be right for
Amyotrophic Lateral SclerosisMultiple Sclerosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 60
Early research (Phase 1)Study completedNCT04204889
What this trial is testing

Trial of Oxaloacetate in ALS

Who this might be right for
ALS
Omar Jawdat 18
Not applicableEnded earlyNCT02058732
What this trial is testing

Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Michigan 6
Not applicableStudy completedNCT00718393
What this trial is testing

Compassionate Use of Ceftriaxone in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisCerebrospinal FluidNeurodegenerative Disease+1 more
Drexel University College of Medicine 1
Early research (Phase 1)Study completedNCT02525471
What this trial is testing

A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
ALS
Sabrina Paganoni, M.D. 24
Early research (Phase 1)Study completedNCT04090684
What this trial is testing

Ciprofloxacin/Celecoxib Combination in Patients With ALS

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
NeuroSense Therapeutics Ltd. 10
Not applicableStudy completedNCT03192358
What this trial is testing

Physiological Flow of Liquids Used in Dysphagia Management (Neuro)

Who this might be right for
Amyotrophic Lateral SclerosisParkinson DiseaseDysphagia
University Health Network, Toronto 40
Testing effectiveness (Phase 2)Study completedNCT03160898
What this trial is testing

Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 458
Early research (Phase 1)Study completedNCT00580593
What this trial is testing

Trial of Early Noninvasive Ventilation for Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Michigan 60
Very early researchStudy completedNCT04575727
What this trial is testing

Exploratory Evaluation of [11C]MPC6827

Who this might be right for
Neurodegenerative DiseasesAlzheimer DiseaseAmyotrophic Lateral Sclerosis
Columbia University 17
Testing effectiveness (Phase 2)Looking for participantsNCT06598202
What this trial is testing

Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Xuanwu Hospital, Beijing 38
Testing effectiveness (Phase 2)Study completedNCT00931944
What this trial is testing

Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 74
Not applicableStudy completedNCT01911130
What this trial is testing

Longitudinal Study of Outcomes Measures in ALS Trials

Who this might be right for
Amyotrophic Lateral Sclerosis
Massachusetts General Hospital 100
Testing effectiveness (Phase 2)Temporarily pausedNCT03755167
What this trial is testing

A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Immunity Pharma Ltd. 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06365216
What this trial is testing

ALS Phase II Study of NX210c

Who this might be right for
Amyotrophic Lateral Sclerosis
Axoltis Pharma 80
Not applicableUnknownNCT05328492
What this trial is testing

Volume Mode Non-invasive Ventilation in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisRespiratory FailureRespiratory Insufficiency+5 more
University Hospitals Coventry and Warwickshire NHS Trust 40
Early research (Phase 1)Ended earlyNCT04749433
What this trial is testing

Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Johns Hopkins University 4
Next Page